Live Chat

CFD:er är komplexa instrument som innebär hög risk att du förlorar pengar snabbt på grund av hävstången. 74% av icke-professionella investerares konton förlorar pengar när de handlar med CFD:er hos den här leverantören. Du bör överväga om du förstår hur CFD:er fungerar och om du har råd att ta den höga risken att förlora dina pengar.

Close

JnJ realtidsdiagram

Instrumentfundament

Weekly Search
Weekly
Daily
Datum Stäng Förändring Förändring (%) Öppna Hög Låg

Nyheter

Info

Spread

0.97

Spread (%)

0.6389 %

Hävstångseffekt

1:2

Köp till dagslåneränta

-0.0597 %

Sälj till dagslåneränta

-0.0292 %

Valuta

USD

Handelstider

Marknaden är öppen

Torsdag

14:31 - 20:59

Måndag

14:31-20:59

Tisdag

14:31-20:59

Onsdag

14:31-20:59

Fredag

14:31-20:59

Analys och statistik

Öppna

---

Föregående stängning

---

52 veckors högsta/lägsta

--- – ---

Marknadsvärde

368943726592

Utelöpande aktier

2407620096

Rapportdatum (nästa)

2001-06-13

Utd-procent

2024-12-10

Datum efter utdelning

2024-11-26

Förväntad framtida årlig utdelningsprocent

4.96

Förväntad framtida årlig direktavkastning

0.0325

Vinst per aktie

6.07

Läs mer om detta instrument

JnJ Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Läs mer om detta instrument

Tillgång
Sälj
Köp
Förändring (%)
Relaterade instrument

Senaste nyheter

Håll dig uppdaterad med de senaste ekonominyheterna från hela världen.

Dogecoin surges

Onsdag, 13 November 2024

Dogecoin surges as Trump unveils new government efficiency initiative with Musk andRamaswamy

Onsdag, 13 November 2024

Japanese Yen to USD: Yen drops to fresh multi-month low against USD

Onsdag, 13 November 2024

Asia markets today: Nikkei 225 up 0.18%, Hang Seng Index falls by 197 points

Tisdag, 12 November 2024

UK stock market news: Helium One share price trading 16.1% higher

Tisdag, 12 November 2024

Leveraged ETF to package Warren Buffett's Berkshire Hathaway B stock

Tisdag, 12 November 2024

Dogecoin surges 20% after Department of Government Efficiency announcement

Tisdag, 12 November 2024

Dow Jones Dips Ahead of CPI Inflation Data; Tesla shares up

Måndag, 11 November 2024

Stock market today: Trump trade powers Dow Johns, S&P 500, Tesla and bitcoin

Trustpilot
Live Chat